Article: LUNESTA(TM) Data Presented at American College of Rheumatology Annual Scientific Meeting; Pilot Study Shows Improvement for Insomnia Patients With Co-Existing Rheumatoid Arthritis.

Article: Results of Sepracor's LUNESTA(R) Next-Day Driving Study in ...
Business Wire;  December 6, 2006 ;     700+ words ... ... of results from a study of LUNESTA([R]) brand eszopiclone ... be presented today at the American College of Neuropsychopharmacology ... insomnia administered either LUNESTA 3 mg or placebo the evening ... nighttime administration of LUNESTA 3 mg, compared with placebo ...

Article: Data Show Sepracor's Lunesta(R) Improved Insomnia in ...
Business Wire;  December 5, 2006 ;     700+ words ... ... Results Presented at American College of Neuropsychopharmacology ... efficacy and safety of LUNESTA([R]) brand eszopiclone ... annual meeting of the American College of Neuropsychopharmacology ... of GAD, and either LUNESTA 3 mg (n=294) or ...

Article: Sepracor Announces Presentation of LUNESTA(TM) Data at ...
Business Wire;  May 25, 2006 ;     700+ words ... ... placebo, patients administered LUNESTA also reported improvements ... baseline, patients administered LUNESTA reported improvement in the ... symptoms: p=0.019), in the American College of Rheumatology RA Joint Assessment ... patients administered placebo. LUNESTA was generally well tolerated ...

Article: LUNESTA(TM) Brand Eszopiclone, Formerly ESTORRA, Approved ...
PR Newswire;  December 16, 2004 ;     700+ words ... ... approved the New Drug Application (NDA) for LUNESTA(TM) brand eszopiclone, formerly referred ... for the FDA's decision to not limit LUNESTA's indication to short-term use. Sepracor ... study with no evidence of tolerance." LUNESTA is indicated for the treatment of patients ...

Article: LUNESTA(TM) Now Widely Available by Prescription to Treat ...
PR Newswire;  April 7, 2005 ;     700+ words ... ... Sepracor Inc. today announced that LUNESTA(TM) (eszopiclone 1 mg, 2 mg and 3 ... prescription in most pharmacies nationwide. LUNESTA is the first and only sleep aid (prescription ... for long-term treatment of insomnia. LUNESTA is the first treatment in its class that ...

Article: LUNESTA(TM) Perimenopause-Menopause Study Data to Be ...
Business Wire;  September 30, 2005 ;     700+ words ... ... study evaluating safety and efficacy of LUNESTA(TM) brand eszopiclone for treatment ... placebo-controlled study, nightly use of LUNESTA 3 mg resulted in statistically significant ... treatment period. Patients treated with LUNESTA also demonstrated significant improvements ...

Article: Lunesta Data to Be Presented at American Psychiatric ...
Business Wire;  May 19, 2005 ;     700+ words ... ... that Phase III/IV clinical data for LUNESTA(TM) brand eszopiclone for the treatment ... Primary Insomnia Sepracor will also have a LUNESTA Booth (booth #2742) at APA from May ... began full-scale commercial launch of LUNESTA. LUNESTA, which is indicated for the ...